Autolus Therapeutics (AUTL) Inventory (2024 - 2025)
Autolus Therapeutics posted quarterly Inventory of $33.2 million for Q4 2025, up 702.54% year-on-year from $4.1 million in Q4 2024, and up 19.79% on a QoQ basis from $27.7 million in Q3 2025.
Autolus Therapeutics (AUTL) has 2 years of Inventory data on file, last reported at $33.2 million in Q4 2025.
- For the quarter ending Q4 2025, Inventory rose 702.54% year-over-year to $33.2 million; the trailing twelve-month figure through Dec 2025 stood at $33.2 million (up 702.54% YoY), and the FY2025 full-year result was $33.2 million, up 702.54% from the prior year.
- Inventory for Q4 2025 stood at $33.2 million, up from $27.7 million in the prior quarter.
- Across five years, Inventory topped out at $33.2 million in Q4 2025 and bottomed at $4.1 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 32.00 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.77 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 3.10 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 84.03 Mn |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn | 33.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 33.21 Mn |
| Sep 30, 2025 | 27.72 Mn |
| Jun 30, 2025 | 23.94 Mn |
| Mar 31, 2025 | 14.65 Mn |
| Dec 31, 2024 | 4.14 Mn |